HEPA

Hepion Pharmaceuticals
HEPA

Delisted

HEPA was delisted on the 12th of May, 2025.

Back to rankings

4 hedge funds and large institutions have $2.75M invested in Hepion Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

1
-$1.39M
2
-$172K
3
-$116K
4
PFS
Prospera Financial Services
Texas
-$99K
5
CS
Credit Suisse
Switzerland
-$87K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.29M
2
$540K
3
$180K
4
$153K
5
$126K
6
$105K
7
$78K
8
$57K
9
$37K
10
$31K
11
$27K
12
$26K
13
$21K
14
$18K
15
$17K
16
$11K
17
$8K
18
$8K
19
$5K
20
$3K
21
$2K
22
$2K
23
$1K
24
–
25
–
1
2